Walleye Capital’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,436
Closed -$66.8K 5164
2025
Q1
$66.8K Sell
11,436
-90,121
-89% -$475K ﹤0.01% 3769
2024
Q4
$378K Sell
101,557
-103,061
-50% -$476K ﹤0.01% 3223
2024
Q3
$1.14M Buy
204,618
+129,043
+171% +$903K ﹤0.01% 2513
2024
Q2
$636K Buy
75,575
+41,139
+119% +$439K ﹤0.01% 3290
2024
Q1
$497K Buy
34,436
+14,086
+69% +$233K ﹤0.01% 3203
2023
Q4
$438K Sell
20,350
-98,414
-83% -$1.76M ﹤0.01% 3050
2023
Q3
$2.28M Buy
118,764
+89,179
+301% +$1.9M 0.01% 1625
2023
Q2
$752K Sell
29,585
-76,911
-72% -$2.22M ﹤0.01% 2094
2023
Q1
$3.85M Buy
106,496
+80,908
+316% +$2.84M 0.06% 411
2022
Q4
$1.01M Buy
25,588
+19,769
+340% +$822K 0.02% 994
2022
Q3
$271K Sell
5,819
-15,472
-73% -$718K 0.01% 1900
2022
Q2
$933K Buy
21,291
+12,453
+141% +$685K 0.03% 685
2022
Q1
$639K Sell
8,838
-3,771
-30% -$272K 0.02% 888
2021
Q4
$1.02M Buy
12,609
+8,781
+229% +$880K 0.03% 580
2021
Q3
$446 Buy
+3,828
New +$501K 0.01% 831
2020
Q4
Sell
-1,697
Closed -$236K 1136
2020
Q3
$236K Buy
+1,697
New +$227K 0.03% 566
2019
Q4
Sell
-310
Closed -$27K 2346
2019
Q3
$27K Buy
310
+190
+158% +$14.4K ﹤0.01% 1702
2019
Q2
$8K Buy
+120
New +$7.47K ﹤0.01% 1612
2018
Q3
$212K Buy
+3,716
New +$232K 0.1% 212

Other funds holding NVRO

Walleye Capital's NVRO Position: Q2 2025 in Review

Walleye Capital sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 11,436 shares — an estimated $66.8K sold.

Walleye Capital first reported a position in NVRO in Q3 2018 and held it in 19 quarters. The position peaked at $3.85M in Q1 2023. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Walleye Capital reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Walleye Capital sold 11,436 NEVRO CORP. shares in Q2 2025, an estimated $66.8K.
  • Walleye Capital first reported a position in NEVRO CORP. in Q3 2018 and held it in 19 quarters.
  • Walleye Capital's NEVRO CORP. position peaked at $3.85M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Walleye Capital's 13F filing for Q2 2025, filed 13 Aug 2025.